ProteoTech, Inc., a privately held biotechnology company, announced a funding agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTechís therap"> MJFF Awardee Announces Collaborative Agreement With GlaxoSmithKline | Parkinson's Disease

EMAIL TO A FRIEND

Close